» Articles » PMID: 37857014

Naked Cuticle Homolog 1 Prevents Mouse Pulmonary Arterial Hypertension Via Inhibition of Wnt/β-catenin and Oxidative Stress

Overview
Specialty Geriatrics
Date 2023 Oct 19
PMID 37857014
Authors
Affiliations
Soon will be listed here.
Abstract

Pulmonary arterial hypertension (PAH) is a poorly prognostic cardiopulmonary disease characterized by abnormal contraction and remodeling of pulmonary artery (PA). Excessive proliferation and migration of pulmonary arterial smooth muscle cells (PASMCs) are considered as the major etiology of PA remodeling. As a negative regulator of Wnt/β-catenin pathway, naked cuticle homolog 1 (NKD1) is originally involved in the tumor growth and metastasis via affecting the proliferation and migration of different types of cancer cells. However, the effect of NKD1 on PAH development has not been investigated. In the current study, downregulated NKD1 was identified in hypoxia-challenged PASMCs. NKD1 overexpression by adenovirus carrying vector encoding (Ad-) repressed hypoxia-induced proliferation and migration of PASMCs. Mechanistically, upregulating NKD1 inhibited excessive reactive oxygen species (ROS) generation and β-catenin expression in PASMCs after hypoxia stimulus. Both inducing ROS and recovering β-catenin expression abolished NKD1-mediated suppression of proliferation and migration in PASMCs. , we also observed decreased expression of NKD1 in dissected PAs of monocrotaline (MCT)-induced PAH model. Upregulating NKD1 by Ad- transfection attenuated the increase in right ventricular systolic pressure (RVSP), right ventricular hypertrophy index (RVHI), pulmonary vascular wall thickening, and vascular β-catenin expression after MCT treatment. After recovering β-catenin expression by SKL2001, the vascular protection of external expression of NKD1 was also abolished. Taken together, our data suggest that NKD1 inhibits the proliferation, migration of PASMC, and PAH via inhibition of β-catenin and oxidative stress. Thus, targeting NKD1 may provide novel insights into the prevention and treatment of PAH.

Citing Articles

Inhibition of CB1R in the Hypothalamic Paraventricular Nucleus Ameliorates Hypertension Through Wnt/β-Catenin/RAS Pathway.

Gao H, Yang Y, Tian H, Fu L, Liu K, Jia X Cardiovasc Toxicol. 2024; 25(1):9-23.

PMID: 39467886 DOI: 10.1007/s12012-024-09938-2.

References
1.
Lozano E, Sanchon-Sanchez P, Morente-Carrasco A, Chinchilla-Tabora L, Mauriz J, Fernandez-Palanca P . Impact of Aberrant β-Catenin Pathway on Cholangiocarcinoma Heterogeneity. Cells. 2023; 12(8). PMC: 10136857. DOI: 10.3390/cells12081141. View

2.
Liu G, Wan N, Liu Q, Chen Y, Cui H, Wang Y . Resolvin E1 Attenuates Pulmonary Hypertension by Suppressing Wnt7a/β-Catenin Signaling. Hypertension. 2021; 78(6):1914-1926. DOI: 10.1161/HYPERTENSIONAHA.121.17809. View

3.
Zhou P, Zhang X, Guo M, Guo R, Wang L, Zhang Z . Ginsenoside Rb1 ameliorates CKD-associated vascular calcification by inhibiting the Wnt/β-catenin pathway. J Cell Mol Med. 2019; 23(10):7088-7098. PMC: 6787443. DOI: 10.1111/jcmm.14611. View

4.
Al-Kenany S, Al-Shawi N . Protective effect of cafestol against doxorubicin-induced cardiotoxicity in rats by activating the Nrf2 pathway. Front Pharmacol. 2023; 14:1206782. PMC: 10291064. DOI: 10.3389/fphar.2023.1206782. View

5.
Xu D, Hu Y, Gou X, Li F, Yang X, Li Y . Oxidative Stress and Antioxidative Therapy in Pulmonary Arterial Hypertension. Molecules. 2022; 27(12). PMC: 9229274. DOI: 10.3390/molecules27123724. View